Compare SpaceX (SPCX) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SpaceX vs BIO-TECHNE Corp — how do they compare? SpaceX trades at $123.46 (market cap $1.58T), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: SpaceX is far larger — about 141.6× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| SPCX | TECH | |
|---|---|---|
Market Cap | $1.58T | $11.16B |
Sector | Technology | Health |
52-Week High | $202.09 | $72.12 |
52-Week Low | $119.85 | $43.31 |
Enterprise Value | $1.59T | $11.24B |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPCX trades at $123.46, down 0.43% amid bearish technical signals despite recent rebound attempts. The company shows strong revenue growth with $18.67B in 2025 but faces significant profitability challenges with a -45% net income margin. Analyst consensus remains strongly bullish with a $237.78 price target, though upcoming August earnings and share unlock events create near-term uncertainty.
While SpaceX maintains strong revenue momentum and AI infrastructure potential, investors face substantial risks from persistent losses, high valuations, and imminent share dilution. The stock's technical weakness contrasts with Wall Street's long-term optimism, creating a high-risk, high-reward scenario dependent on upcoming earnings execution and competitive positioning.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
